Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with AstraZeneca about the collapse of Avara Avlon and enhanced redundancy pay for employees.
My rt. hon. Friend the Secretary of State has had no discussions with AstraZeneca. This is a commercial matter which BEIS have been monitoring for some time, however we have not sought to intervene while staff consultation and the administration process are underway.
AstraZeneca announced yesterday that they have set aside funding of up to £12m, to be administered independently, to make sure their former employees at the Avlon site receive full severance should the ongoing administration of the site not generate enough funds to cover redundancy costs.